Document Type


Publication Date



Introduction: As of January 26, 2021, there have been 1,988,063 confirmed cases with 34,701 fatalities from COVID-19 in the state of Texas. As the fatalities increased in Rio Grande Valley, there was overwhelming evidence that showed that obesity, an already hypercoagulable state, was a risk factor that contributed to the severity of COVID-19 infection (Sanchis-Gomar, et. Al. 2020). The prevalence of obesity amongst the population in in the RGV presents an opportunity to correlate trends in outcomes with the obese population that are admitted for inpatient management of COVID-19.

Materials and Methods: This retrospective cohort study looks at patient’s electronic medical records who were admitted to Valley Baptist Medical Center patients at VBMC from February 28, 2020 to August 3, 2020.

Results: Obese and overweight patients accounted for the majority of hospitalizations and fatalities from COVID-19. There were 12 different anticoagulation doses and 2 antiplatelet therapies used to manage these patients.

Conclusion: Additional studies on anticoagulation therapy on COVID-19 patients are needed, particularly for obese patients.

Academic Level

medical student

Mentor/PI Department

Internal Medicine



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.